Erbitux 100 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB25FQ0X2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,718
Award facts
- Contract value 100% obligated
- $19,718.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,718.40 to AmerisourceBergen Drug Corp for the supply of Erbitux (cetuximab) 100 mg/50 mL vials on August 29, 2025, with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet complex medical procurement requirements through open competition. Erbitux, a monoclonal antibody cancer treatment, represents the type of specialized pharmaceutical product within AmerisourceBergen's comprehensive offerings under its DLA prime vendor agreement, which enables global pharmaceutical support for Defense Health Agency customers and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ0X2?
SPE2DB25FQ0X2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FQ0X2 worth?
The government has obligated $19,718 on SPE2DB25FQ0X2.
Is contract SPE2DB25FQ0X2 an order under another contract?
Yes. SPE2DB25FQ0X2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0X2 competed?
The extent of competition for SPE2DB25FQ0X2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award